SonoSite’s portable ultrasound machines are intuitive, durable, and backed by a 5-year warranty. Our machines undergo rigorous durability testing, hours of quality assurance, and are designed with clinicians from the ground up. As a company, we’re committed to spreading point-of-care ultrasound education through online webinars, in-person education and our mobile app.

• We make our ultrasound equipment tough because you need to focus on providing care to your patient, not on whether your machine needs repair.
•  We make our machines intuitive because the last thing you need is an ultrasound machine you can’t figure out how to use.
• We provide access to educational resources because we’re committed to helping you improve patient outcomes. 
• Our machines are ready to go when you are. And should a problem arise, your ultrasound machine is backed by a 5-year warranty

Read more

Carestream will showcase its CARESTREAM Touch Prime and Touch Prime XE Ultrasound Systems at the 28th Euroson Congress of the EFSUMB taking place in Leipzig, Germany from 26 to 29 October. Both Touch Prime and Touch Prime XE systems provide exceptional image quality. They also streamline measurements to expedite clinician access to critical imaging information while boosting staff productivity. Advanced computing power and the company’s SynTek architecture deliver a simultaneous increase in frame rate, improved penetration and uniform focus throughout the field of view. Touch Prime and Touch Prime XE systems offer Smart Flow, Smart Flow Assist and Smart Select technology designed to further enhance workflow.
Smart Flow imaging technology eliminates the transducer angle limitations of ordinary Doppler ultrasound, and its proprietary Smart Flow method can visualize and measure velocity even when blood flow is perpendicular to the acoustic beam. The resulting measurements are angle independent-and therefore less prone to measurement error. The new ultrasound systems also visualize blood flow in all directions including axial and transverse, which provides more comprehensive information about hemodynamics to assist with diagnostic decisions. The benefits offered by this advanced ultrasound imaging technology can play a vital role in accurately assessing clinical applications such as evaluation of hemodialysis vascular access (AV fistulas and grafts) and quantification of complex flow patterns in the presence of stenosis. Colour coding and arrows automatically display information from Smart Flow technology on the Touch Prime Ultrasound platform. The length of the arrow, in addition to the colour, indicates magnitude. The orientation of the arrow indicates flow direction. Ordinary colour and spectral Doppler ultrasound only measure velocity of flow components toward or away from a transducer.
Smart Flow Assist automatically determines the highest area of flow, and places and adjusts sample size as well as angle corrections. This reduces the number of key strokes for velocity and volume measurements. Integrated one-touch transducer activation and a mode-programmable Smart Select button on the transducers allow a sonographer to reduce key strokes and improve productivity. A single touch of a button allows the user to activate the transducer as well as program two additional functions from a list of 16 commonly used functions.
Carestream’s advanced SynTek Architecture simultaneously provides enhanced spatial detail with increased frame rates for improved visualization of moving structures, while optimizing image formation to reduce noise and artifacts. Imaging and Doppler improvements allow for more consistent visualization of subtle tissue contrast differences and can increase the ability to see small structures. These systems also deliver uniform lateral resolution over the entire depth and deeper penetration for imaging of the abdomen and other areas.
Carestream offers specialized transducers for vascular imaging as well as radiology, OB/GYN and musculoskeletal imaging. A direct transducer interface to the ultrasound processing board delivers lower noise and higher image quality, and four transducers can be connected simultaneously to any of the system’s four ports.
The Touch Prime XE is capable of frame rates in excess of 100Hz while maintaining enhanced imaging detail, and includes optional features such as a DICOM package, barcode and RFID badge readers. Wireless connectivity provides rapid image transfers to PACS, RIS and other systems. An integrated gel warmer delivers added convenience and patient comfort.
The Touch Ultrasound platform’s design is based upon recommendations by sonographers and ultrasound professionals across the world. These systems have earned praise for a sealed, all-touch control panel that combines the speed and flexibility of a soft user interface with the tactile feedback of traditional keys. Etched marking for primary controls equips the user to easily locate frequently used functions without looking away from the image display monitor.
Read more

The Affirm prone biopsy system is the first dedicated prone biopsy system capable of both stereotactic and tomosynthesis-guided breast biopsies. The Affirm prone biopsy system is CE marked and pending 510k clearance in the U.S. The new system complements Hologic’s Selenia Dimensions mammography system and Affirm upright biopsy system to ensure that facilities have all the options necessary to provide minimally invasive breast biopsy to their patients. The Affirm prone system provides enhanced biopsy performance over existing prone systems with exceptional biopsy imaging capabilities using the same detector technology as the Hologic tomosynthesis mammography system; a streamlined workflow designed to make the system fast and easy to use; access to challenging lesion locations with a fully integrated C-arm. The C-arm allows a full 360° access to the breast with both standard and lateral needle approaches—without requiring additional accessory attachments.
Read more

ZedScan is a portable, handheld device that uses patented Electrical Impedance Spectroscopy (EIS) to detect the development of pre-cancerous abnormalities of the cervix, known as cervical intraepithelial neoplasia (CIN). The innovative system not only removes subjectivity and increases accuracy, but it also helps clinicians manage growing colposcopy referrals generated by the introduction of primary HPV testing. In a recent review of over 1500 women referred to an NHS colposcopy clinic, the adoption of ZedScan resulted in a significant increase in disease detection and improvements in clinical performance. The patient case study revealed a 13% increase in detection of high-grade disease (HGCIN) across all patients, with 50% increase reported in women with low-grade cytology. In 92% of these cases, disease was confirmed with a single biopsy. If rolled out across the UK, this would equate to an additional 200 women being identified with HGCIN every week, or approximately 10,000 women each year who can therefore be diagnosed and treated much earlier. Thus preventing disease from developing. Performance was not impacted by the hrHPV genotype with increased detection in both HPV16 and non 16 hrHPV positive women. Cervical cancer is the 7th most common disease globally, and the third most prevalent in woman. The disease is caused by the persistent high-risk human papillomavirus (HPV) infection, which triggers changes in the cervical cells. Although colposcopy is an important method in detecting cervical cancer, in practice, the procedure has not drastically changed over the last 90 years, and diagnosis depends on the subjective assessment of visual indicators by the clinician. An objective assessment will help clinicians to better manage patients and help avoid unnecessary biopsies, treatments and repeat follow-up appointments.

Read more

To sharply focus on the specialized requirements in echocardiography, Toshiba engineers have built the new Aplio i900CV with a total redesign of hardware and software. The new Aplio i-series is a premium addition to the award-winning Aplio 500 platform, which is used in over 31,000 clinical settings to date. The system works very fast with a reduced requirement for user interaction, which translates into a significant time saving for the echocardiography lab.
The Aplio i-series features an architecture that gives it on-board capabilities for ultra-fast processing of advance applications, and with a new range of high frequency and ultra-wideband transducers. New with the Aplio i900CV is a 3-D transesophageal echocardiography (TEE) transducer that brings the possibility to view aortic leaflets, or to measure mitral valve parameters where it is possible not only to see the opening, but even also the stitches where the valve has been repaired. Yet, thanks to the new ultra-wideband transducers, a TEE exam is not always required. With the wider coverage and the extremely good penetration up to 28 centimetres, it is possible to evaluate the aortic valve area with a transthoracic approach. Clinicians are able to see distinctly four-chamber views, and have found excellent resolution in subcostal
views. Using a hybrid format in one display makes it possible to see calcified segments of coronary arteries derived from CT along with a quantification of the stenosis thanks to 3-D strain imaging, and at the same time a superimposition to the myocardium derived by CT. Using an innovative tool called Activation Imaging, it is possible to add measurements to determine torsion, an important parameter for a variety of diseases, or see areas where there is delayed contraction. Rest and stress, related to a specific coronary artery, can be seen as a superimposition on a CT image, enabling clinicians to make a decision as to intervention. At the heart of an enhanced image quality is the iBeam technology. Electrical dynamic focus with individual matrix element control and multiplexing with ultra-fast processing narrows and sharpens the signal for real-time 3-D beam forming. Advanced features include Superb Micro-Vascular Imaging (SMI) that combines the new transducers for more brilliant images with reduced motion artefacts, allowing extensive perfusion examination capabilities across all regions of human anatomy; Quad Fusion capability for interventional procedures or advanced diagnostics, with a simultaneous combination of CT/MRI images with real-time ultrasound and 3-D ultrasound rendering of a live procedure; super precise 3-D imaging boosted by Aplio i-series iBeam and thin slice acquisition to render near-photo quality images of anatomical structures.
Read more